APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infliximab Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Infliximab Injection Industry Growth and Trends Forecast to 2032

28 December 2025104 pages

Choose your research edition.

Industry ResearchInfliximab Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Infliximab Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Infliximab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infliximab Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Infliximab Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Infliximab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Infliximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Infliximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infliximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Infliximab Injection include Yuxi Jiahe Biotechnology, Taizhou Maiboteike Pharmaceuticals, Hangzhou Bozhirui Biopharmaceuticals, Pfizer, Nippon Kayaku, Nichiiko, Janssen Biologics, Celltrion and Ayumi Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Infliximab Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Infliximab Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Infliximab Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Infliximab Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Infliximab Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Infliximab Injection Market by Company

Yuxi Jiahe Biotechnology

Taizhou Maiboteike Pharmaceuticals

Hangzhou Bozhirui Biopharmaceuticals

Pfizer

Nippon Kayaku

Nichiiko

Janssen Biologics

Celltrion

Ayumi Pharmaceuticals

AMGEN

Infliximab Injection Segment by Type

Original Drug

Generic Drug

Infliximab Injection Segment by Application

Hospital

Clinic

Other

Infliximab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infliximab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infliximab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infliximab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Infliximab Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Infliximab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Infliximab Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Infliximab Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Infliximab Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Infliximab Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Infliximab Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Infliximab Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Infliximab Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Infliximab Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Infliximab Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Infliximab Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Infliximab Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Infliximab Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Infliximab Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Infliximab Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Infliximab Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Infliximab Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Infliximab Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Infliximab Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Infliximab Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Infliximab Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Infliximab Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Infliximab Injection Industry Trends Table 25. Infliximab Injection Industry Drivers Table 26. Infliximab Injection Industry Opportunities and Challenges Table 27. Infliximab Injection Industry Restraints Table 28. Global Infliximab Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Infliximab Injection Revenue Market Share by Company (2021-2026) Table 30. Global Infliximab Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Infliximab Injection Sales Share by Company (2021-2026) Table 32. Global Infliximab Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Infliximab Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Infliximab Injection Major Company Production Sites and Headquarters Table 35. Global Infliximab Injection Company, Product Type & Application Table 36. Global Infliximab Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Infliximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Infliximab Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Infliximab Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Infliximab Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Infliximab Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Infliximab Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Infliximab Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Infliximab Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Infliximab Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Infliximab Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Infliximab Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Infliximab Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Infliximab Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Infliximab Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Infliximab Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Infliximab Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Infliximab Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Infliximab Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Infliximab Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Infliximab Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Infliximab Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Infliximab Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Infliximab Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Infliximab Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Infliximab Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Infliximab Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Infliximab Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Infliximab Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Infliximab Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Infliximab Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Infliximab Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Infliximab Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Infliximab Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Yuxi Jiahe Biotechnology Company Information Table 72. Yuxi Jiahe Biotechnology Business Overview Table 73. Yuxi Jiahe Biotechnology Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolio Table 75. Yuxi Jiahe Biotechnology Recent Development Table 76. Taizhou Maiboteike Pharmaceuticals Company Information Table 77. Taizhou Maiboteike Pharmaceuticals Business Overview Table 78. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolio Table 80. Taizhou Maiboteike Pharmaceuticals Recent Development Table 81. Hangzhou Bozhirui Biopharmaceuticals Company Information Table 82. Hangzhou Bozhirui Biopharmaceuticals Business Overview Table 83. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolio Table 85. Hangzhou Bozhirui Biopharmaceuticals Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Infliximab Injection Product Portfolio Table 90. Pfizer Recent Development Table 91. Nippon Kayaku Company Information Table 92. Nippon Kayaku Business Overview Table 93. Nippon Kayaku Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Nippon Kayaku Infliximab Injection Product Portfolio Table 95. Nippon Kayaku Recent Development Table 96. Nichiiko Company Information Table 97. Nichiiko Business Overview Table 98. Nichiiko Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Nichiiko Infliximab Injection Product Portfolio Table 100. Nichiiko Recent Development Table 101. Janssen Biologics Company Information Table 102. Janssen Biologics Business Overview Table 103. Janssen Biologics Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Janssen Biologics Infliximab Injection Product Portfolio Table 105. Janssen Biologics Recent Development Table 106. Celltrion Company Information Table 107. Celltrion Business Overview Table 108. Celltrion Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Celltrion Infliximab Injection Product Portfolio Table 110. Celltrion Recent Development Table 111. Ayumi Pharmaceuticals Company Information Table 112. Ayumi Pharmaceuticals Business Overview Table 113. Ayumi Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Ayumi Pharmaceuticals Infliximab Injection Product Portfolio Table 115. Ayumi Pharmaceuticals Recent Development Table 116. AMGEN Company Information Table 117. AMGEN Business Overview Table 118. AMGEN Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. AMGEN Infliximab Injection Product Portfolio Table 120. AMGEN Recent Development Table 121. North America Infliximab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Infliximab Injection Sales by Country (2021-2026) & (K Units) Table 123. North America Infliximab Injection Sales Market Share by Country (2021-2026) Table 124. North America Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Infliximab Injection Sales Market Share Forecast by Country (2027-2032) Table 126. North America Infliximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Infliximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Infliximab Injection Market Share by Country (2021-2026) Table 129. North America Infliximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Infliximab Injection Market Share Forecast by Country (2027-2032) Table 131. Europe Infliximab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Infliximab Injection Sales by Country (2021-2026) & (K Units) Table 133. Europe Infliximab Injection Sales Market Share by Country (2021-2026) Table 134. Europe Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Infliximab Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Infliximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Infliximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Infliximab Injection Market Share by Country (2021-2026) Table 139. Europe Infliximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Infliximab Injection Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Infliximab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Infliximab Injection Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Infliximab Injection Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Infliximab Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Infliximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Infliximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Infliximab Injection Market Share by Country (2021-2026) Table 149. Asia-Pacific Infliximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Infliximab Injection Market Share Forecast by Country (2027-2032) Table 151. Latin America Infliximab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Infliximab Injection Sales by Country (2021-2026) & (K Units) Table 153. Latin America Infliximab Injection Sales Market Share by Country (2021-2026) Table 154. Latin America Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Infliximab Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Infliximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Infliximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Infliximab Injection Market Share by Country (2021-2026) Table 159. Latin America Infliximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Infliximab Injection Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Infliximab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Infliximab Injection Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Infliximab Injection Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Infliximab Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Infliximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Infliximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Infliximab Injection Market Share by Country (2021-2026) Table 169. Middle East and Africa Infliximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Infliximab Injection Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Infliximab Injection Distributors List Table 174. Infliximab Injection Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Infliximab Injection Image Figure 2. Global Infliximab Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infliximab Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Infliximab Injection Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Infliximab Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Infliximab Injection Market Share by Type 2025 VS 2032 Figure 11. North America Infliximab Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Infliximab Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Infliximab Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Infliximab Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Infliximab Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Infliximab Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Infliximab Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Infliximab Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Infliximab Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Infliximab Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Infliximab Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Infliximab Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Infliximab Injection Market Share by Application 2025 VS 2032 Figure 31. North America Infliximab Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Infliximab Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Infliximab Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Infliximab Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Infliximab Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Infliximab Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Infliximab Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Infliximab Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Infliximab Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Infliximab Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Infliximab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Infliximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Infliximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Infliximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Infliximab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Infliximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Infliximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Infliximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Infliximab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Infliximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Infliximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Infliximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Infliximab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Infliximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Infliximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Infliximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Infliximab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Infliximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Infliximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Infliximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Infliximab Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Infliximab Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yuxi Jiahe Biotechnology
  • Taizhou Maiboteike Pharmaceuticals
  • Hangzhou Bozhirui Biopharmaceuticals
  • Pfizer
  • Nippon Kayaku
  • Nichiiko
  • Janssen Biologics
  • Celltrion
  • Ayumi Pharmaceuticals
  • AMGEN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Infliximab Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Infliximab Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Infliximab Injection Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Infliximab Injection Market Size by Type
  9. 1.4.1 Global Infliximab Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Infliximab Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Infliximab Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Infliximab Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Infliximab Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Infliximab Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Infliximab Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Infliximab Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Infliximab Injection Industry Trends
  2. 2.2 Infliximab Injection Industry Drivers
  3. 2.3 Infliximab Injection Industry Opportunities and Challenges
  4. 2.4 Infliximab Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Infliximab Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Infliximab Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Infliximab Injection Price (2021-2026)
  4. 3.4 Global Infliximab Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Infliximab Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Infliximab Injection Company, Product Type & Application
  7. 3.7 Global Infliximab Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Infliximab Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Infliximab Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Infliximab Injection Tier 1, Tier 2, and Tier 3
4 Infliximab Injection Regional Status and Outlook
  1. 4.1 Global Infliximab Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Infliximab Injection Historic Market Size by Region
  3. 4.2.1 Global Infliximab Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Infliximab Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Infliximab Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Infliximab Injection Forecasted Market Size by Region
  7. 4.3.1 Global Infliximab Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Infliximab Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Infliximab Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Infliximab Injection by Application
  1. 5.1 Infliximab Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Infliximab Injection Market Size by Application
  6. 5.2.1 Global Infliximab Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Infliximab Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Infliximab Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Infliximab Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Infliximab Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Infliximab Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Infliximab Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Infliximab Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yuxi Jiahe Biotechnology
  2. 6.1.1 Yuxi Jiahe Biotechnology Company Information
  3. 6.1.2 Yuxi Jiahe Biotechnology Business Overview
  4. 6.1.3 Yuxi Jiahe Biotechnology Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolio
  6. 6.1.5 Yuxi Jiahe Biotechnology Recent Developments
  7. 6.2 Taizhou Maiboteike Pharmaceuticals
  8. 6.2.1 Taizhou Maiboteike Pharmaceuticals Company Information
  9. 6.2.2 Taizhou Maiboteike Pharmaceuticals Business Overview
  10. 6.2.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolio
  12. 6.2.5 Taizhou Maiboteike Pharmaceuticals Recent Developments
  13. 6.3 Hangzhou Bozhirui Biopharmaceuticals
  14. 6.3.1 Hangzhou Bozhirui Biopharmaceuticals Company Information
  15. 6.3.2 Hangzhou Bozhirui Biopharmaceuticals Business Overview
  16. 6.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolio
  18. 6.3.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Infliximab Injection Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Nippon Kayaku
  26. 6.5.1 Nippon Kayaku Company Information
  27. 6.5.2 Nippon Kayaku Business Overview
  28. 6.5.3 Nippon Kayaku Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nippon Kayaku Infliximab Injection Product Portfolio
  30. 6.5.5 Nippon Kayaku Recent Developments
  31. 6.6 Nichiiko
  32. 6.6.1 Nichiiko Company Information
  33. 6.6.2 Nichiiko Business Overview
  34. 6.6.3 Nichiiko Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Nichiiko Infliximab Injection Product Portfolio
  36. 6.6.5 Nichiiko Recent Developments
  37. 6.7 Janssen Biologics
  38. 6.7.1 Janssen Biologics Company Information
  39. 6.7.2 Janssen Biologics Business Overview
  40. 6.7.3 Janssen Biologics Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Janssen Biologics Infliximab Injection Product Portfolio
  42. 6.7.5 Janssen Biologics Recent Developments
  43. 6.8 Celltrion
  44. 6.8.1 Celltrion Company Information
  45. 6.8.2 Celltrion Business Overview
  46. 6.8.3 Celltrion Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Celltrion Infliximab Injection Product Portfolio
  48. 6.8.5 Celltrion Recent Developments
  49. 6.9 Ayumi Pharmaceuticals
  50. 6.9.1 Ayumi Pharmaceuticals Company Information
  51. 6.9.2 Ayumi Pharmaceuticals Business Overview
  52. 6.9.3 Ayumi Pharmaceuticals Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ayumi Pharmaceuticals Infliximab Injection Product Portfolio
  54. 6.9.5 Ayumi Pharmaceuticals Recent Developments
  55. 6.10 AMGEN
  56. 6.10.1 AMGEN Company Information
  57. 6.10.2 AMGEN Business Overview
  58. 6.10.3 AMGEN Infliximab Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AMGEN Infliximab Injection Product Portfolio
  60. 6.10.5 AMGEN Recent Developments
7 North America by Country
  1. 7.1 North America Infliximab Injection Sales by Country
  2. 7.1.1 North America Infliximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Infliximab Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Infliximab Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Infliximab Injection Market Size by Country
  6. 7.2.1 North America Infliximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Infliximab Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Infliximab Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Infliximab Injection Sales by Country
  2. 8.1.1 Europe Infliximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Infliximab Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Infliximab Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Infliximab Injection Market Size by Country
  6. 8.2.1 Europe Infliximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Infliximab Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Infliximab Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Infliximab Injection Sales by Country
  2. 9.1.1 Asia-Pacific Infliximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Infliximab Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Infliximab Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Infliximab Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Infliximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Infliximab Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Infliximab Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Infliximab Injection Sales by Country
  2. 10.1.1 South America Infliximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Infliximab Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Infliximab Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Infliximab Injection Market Size by Country
  6. 10.2.1 South America Infliximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Infliximab Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Infliximab Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Infliximab Injection Sales by Country
  2. 11.1.1 Middle East and Africa Infliximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Infliximab Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Infliximab Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Infliximab Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Infliximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Infliximab Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Infliximab Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Infliximab Injection Value Chain Analysis
  2. 12.1.1 Infliximab Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Infliximab Injection Production Mode & Process
  7. 12.2 Infliximab Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Infliximab Injection Distributors
  10. 12.2.3 Infliximab Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst